Stories

Indonesia starts COVID boosters for elderly, others at risk

Indonesia kicked off a COVID-19 booster campaign for the general public on Wednesday, prioritising third shots for the elderly and people with compromised immune systems.

The government hopes to provide 21 million booster shots in January to people who received their second jabs at least six months ago. Some 117 million people in Indonesia have already received two doses of the vaccine.

This effort is important to increase the immunity of society, considering the COVID-19 virus keeps mutating, President Joko Widodo said Tuesday.

Indonesia has reported more than 4.2 million cases and more than 144,000 deaths since the pandemic began. During the peak of the last surge in July, the country recorded 56,757 cases per day as hospitals were overwhelmed by sick patients and ran out of beds and oxygen supplies.

Indonesia starts COVID boosters for elderly, others at risk | International | whig.com

The country provided the Moderna vaccine as a booster for healthcare workers starting in July last year.

Indonesia’s Food and Drug Authority on Monday approved emergency-use authorization for the Sinovac, Pfizer, AstraZeneca, Moderna and Zifivax vaccines, all of which will be used as booster shots. Several other vaccines are also being examined for emergency-use authorization.

As Europe Sees Covid Surge & India Mulls Booster Shots, Here's a Look at Countries Offering Third Dose

Indonesia’s Health Minister Budi Gunadi Sadikin said the government would consider the availability of vaccines in determining which boosters people will receive and that the boosters might be different from what people received in their first two doses.

People who received the Sinovac vaccine as their primary doses will receive half a dose of the Pfizer vaccine or half a dose of the AstraZeneca vaccine as a booster, while those who received AstraZeneca’s vaccine as their primary doses will receive half a dose of the Moderna vaccine as a booster.

Coronavirus: Canadians aged 30 and older can be offered AstraZeneca jab — as it happened | Financial Times

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker